an avian flu pandemic could kill millions, page-10

stated Dr Warwick Lamb, Managing Director of Imugene. “The gene used is the correct protective gene and once we get correct expression of this gene, we expect effective protection against the Avian Influenza.” “Reconstruction of a new batch of the vaccine will soon commence and trials are expected to be underway early in 2005. The new batch will be tested at several stages to ensure that the defect has been corrected. This will ensure that the protective gene will express as expected,” said Dr Lamb. “With this news and the recent success in gaining a $250,000 BIF grant to develop the Avian Influenza Vaccine, we remain very optimistic that we can develop an effective vaccine against bird flu.” END More information: Dr Warwick Lamb, Mr Graham Dowland, Imugene's Managing Director Imugene's Executive Chairman +61 2 9870 7330 +61 8 9322 9189 Mr Rudi Michelson Monsoon Communications +61 3 9620 3333 ABN: 99 009 179 551
Level 1, 14 – 20 Delhi Road, North Ryde NSW 2113
PO Box 307, North Ryde NSW 1870
Tel: +61 2 9870 7330 Fax: +61 2 9888 9338
website: www.imugene.com